Clinical Trials Logo

Malignant Neoplasm clinical trials

View clinical trials related to Malignant Neoplasm.

Filter by:

NCT ID: NCT02970617 Completed - Malignant Neoplasm Clinical Trials

Ringing a Bell on the Final Day of Radiation Therapy in Improving the Memory of Distress in Cancer Patients

Start date: August 15, 2016
Phase: N/A
Study type: Interventional

This clinical trial studies how well ringing a bell on the final day of radiation therapy works in improving the memory of distress in cancer patients. Ringing a bell on the final day of radiation therapy may improve the memory of how painful the treatment was.

NCT ID: NCT02970045 Recruiting - Malignant Neoplasm Clinical Trials

Norris ORIEN Total Cancer Care

Start date: May 2, 2016
Phase:
Study type: Observational

This research trial collects biological samples and clinical information to create a repository of data from patients with cancer or a predisposition for cancer. Combining genetic information from biological samples and clinical data may lead to more knowledge about why certain cancers respond to treatment and help create more personalized medicine.

NCT ID: NCT02942524 Completed - Malignant Neoplasm Clinical Trials

Checklist Tool in Engaging Patients in the Discharge Planning Process

TEPID
Start date: April 2016
Phase: N/A
Study type: Interventional

This clinical trial studies how well a checklist tool works in engaging patients in the discharge planning process. Engaging patients in the discharge process may increase participation in the discharge process and improve discharge outcomes, understanding of care after hospitalization, and decrease complications.

NCT ID: NCT02888301 Terminated - Malignant Neoplasm Clinical Trials

18F-Clofarabine PET/CT in Imaging Cancer Patients Before and After Interventions

Start date: June 12, 2015
Phase:
Study type: Observational

This clinical trial studies 18F-clofarabine positron emission tomography (PET)/computed tomography (CT) in imaging patients with cancer before and after treatment with a therapy that activates the patient's immune system (immunotherapy). PET/CT scans give detailed pictures of areas inside the body. 18F-clofarabine is a drug that contains a radioactive substance that is taken up by cells expressing deoxycytidine kinase (dCK), which is highly expressed in activated immune cells, making them light up during PET/CT scans. Doctors also want to know how 18F-clofarabine is distributed throughout the body before and after treatment with immunotherapies.

NCT ID: NCT02860039 Active, not recruiting - Influenza Clinical Trials

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

Start date: September 2016
Phase: Phase 2
Study type: Interventional

This phase II randomized trial studies how well high dose flu vaccine works in treating children who have undergone done stem cell transplant. Higher dose flu vaccine may build a better immune response and may provide better protection against the flu than the standard vaccine.

NCT ID: NCT02751580 Completed - Malignant Neoplasm Clinical Trials

Telehealth in Improving Quality of Life in Patients During Post Radiation Therapy Visits

Start date: March 23, 2016
Phase: N/A
Study type: Interventional

This pilot clinical trial studies how well telehealth works in patients during post radiation therapy visits. A telehealth virtual office visit can be performed from the patient's home or workplace, decreasing time spent traveling to visit site, time spent in waiting room, and cost to patient. Studying telehealth may improve quality of life in patients during post radiation therapy visit.

NCT ID: NCT02729883 Terminated - Malignant Neoplasm Clinical Trials

Take the Fight in Supporting and Empowering Patients With Cancer

Start date: February 2016
Phase: N/A
Study type: Interventional

This pilot clinical trial studies Take the Fight in supporting and empowering patients with cancer through their treatment process. Patients with cancer are faced with many obstacles created by the current state of the healthcare system. The purpose of Take the Fight is to train college students, also called patients' navigators or strategists, to assist and support patients to navigate into the healthcare system and receive the care they need. The strategists are matched with patients and attend/coordinate most patients' medical appointments. The strategists also advance communications between the patient and the medical staff to facilitate both the exchange of medical information as well as increase the patient's compliance with treatment. Take the Fight may improve the health and quality of life outcomes of cancer patients during critical treatment periods by increasing treatment compliance, eliminating barriers to better care, and increasing clinical trial participation.

NCT ID: NCT02699697 Recruiting - Pain Clinical Trials

Palliative Radiation Therapy in Reducing Pain in Patients With Bone Metastasis

Start date: May 2016
Phase: N/A
Study type: Interventional

This randomized phase II trial studies how well palliative radiation therapy works in reducing pain in patients with cancer that has spread from the original (primary) tumor to the bone (bone metastasis). Palliative radiation therapy using external beam radiation therapy may help patients with bone metastasis to relieve symptoms and reduce pain caused by cancer.

NCT ID: NCT02696447 Completed - Malignant Neoplasm Clinical Trials

Radiation Impact on Thromboembolic Events

RIT
Start date: June 14, 2016
Phase:
Study type: Observational

The aim of the present study is to determine the frequency and to identify main risk factors for venous thromboembolism of venous thromboembolic complications in a population of cancer patients treated with a curative intent by ionizing radiation.

NCT ID: NCT02688517 Recruiting - Malignant Neoplasm Clinical Trials

Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer

Start date: February 2013
Phase:
Study type: Observational

This research trial studies the use of targeted genomic analysis of blood and tissue samples from patients with cancer. Genomic sequencing is a laboratory method that is used to determine the entire genetic makeup of a specific organism or cell type. Genomic sequencing can be used to find changes in areas of the genome that may be important in the development of cancer. It may also help doctors improve ways to diagnose and treat patients with rare cancers with poor prognosis or lack of effective therapy.